Labat Africa (JSE:LAB) ROE % Adjusted to Book Value: 160.52% (As of Nov. 2025)


What is Labat Africa ROE % Adjusted to Book Value?

Labat Africa JSE:LAB +66.67% ROE % Adjusted to Book Value is 160.52% as of Nov. 2025. The stock has 5 warning signs investors should review.

Labat Africa's ROE % for the quarter that ended in Nov. 2025 was 52.97%. Labat Africa's PB Ratio for the quarter that ended in Nov. 2025 was 0.33. Labat Africa's ROE % Adjusted to Book Value for the quarter that ended in Nov. 2025 was 160.52%.

Labat Africa ROE % Adjusted to Book Value Related Terms

Labat Africa ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for Labat Africa's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Labat Africa ROE % Adjusted to Book Value Chart

Labat Africa Annual Data
Trend Feb14 Feb15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 May23 May24
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 19.18 -23.52 -2.70 0.00

Labat Africa Semi-Annual Data
Aug15 Aug16 Feb17 Aug17 Feb18 Aug18 Feb19 Aug19 Feb20 Aug20 Feb21 Aug21 Feb22 Nov22 May23 Nov23 May24 Nov24 May25 Nov25
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 41.83 0.00 Negative Equity 629.78 160.52

JSE:LAB vs ZTS, UTHR, VTRS: ROE % Adjusted to Book Value Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Labat Africa's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Labat Africa ROE % Adjusted to Book Value vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Labat Africa's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Labat Africa's ROE % Adjusted to Book Value falls into.


Labat Africa ROE % Adjusted to Book Value Calculation

Labat Africa's ROE % Adjusted to Book Value for the fiscal year that ended in May. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=0.00% / N/A
=N/A

Labat Africa's ROE % Adjusted to Book Value for the quarter that ended in Nov. 2025 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=52.97% / 0.33
=160.52%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROE % Adjusted to Book Value of 160.52% mean?
Labat Africa (JSE:LAB) has a ROE % Adjusted to Book Value of 160.52% as of Nov. 2025. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Labat Africa and its competitors.
Is Labat Africa's ROE % Adjusted to Book Value too high?
Labat Africa's current ROE % Adjusted to Book Value is 160.52%.
How does Labat Africa's ROE % Adjusted to Book Value compare to ZTS and UTHR?
Labat Africa's ROE % Adjusted to Book Value of 160.52% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Drug Manufacturers company?
A good ROE % Adjusted to Book Value depends on the Drug Manufacturers industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Labat Africa and its competitors. Labat Africa's current ROE % Adjusted to Book Value is 160.52%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Labat Africa stock overvalued right now?
Based on GuruFocus' analysis, Labat Africa (JSE:LAB) is currently considered Possible Value Trap. The stock's GF Value™ is R0.22, compared to a current price of R0.05 — trading 77.3% below its estimated fair value. The current ROE % Adjusted to Book Value is 160.52%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For Labat Africa (JSE:LAB), the current ROE % Adjusted to Book Value is 160.52% as of Nov. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Labat Africa Business Description

Other Exchanges LAO:Germany
Address 75 Maude StreetSandown, The Leonardo 14th Floor, Sandown, Johannesburg, GT, ZAF, 1709
Labat Africa Ltd is an investment holding company. Through its subsidiaries, the company operates in the following segments; Technology, Head office, and Healthcare. The Technology segment manufactures and distributes integrated circuits South African Micro - Electronic Systems. Head office operations provide management services, logistics and seeks further investment opportunities for the Group. The Healthcare segment generates maximum revenue for the company and focusses on medical cannabis industry in South Africa. Geographically, the company carries out its business operations in South Africa.